Open Access

Why ZEUS? Interleukin-6 as the next potential frontier in anti-inflammatory management of atherosclerotic cardiovascular disease

Event: ESC Congress 2021 - The Digital Experience
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by Novo Nordisk A/S
Date: 29 August 2021
Time: 11:30 - 12:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

2 presentations in this session

In conversation with Drs. Libby & Ridker.

Speaker: Professor P. Libby (Boston, US)
Speaker: Doctor P. Ridker (Boston, US)
Thumbnail

Live panel discussion.

Thumbnail

2 speakers from this session

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
32 presentations
3 followers

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
27 presentations
2 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Valvular Heart Disease

3 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk